Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / Fosun Pharmaceutical Group
Company

Fosun Pharmaceutical Group

Tracked across 2 events · 14 articles · First seen Apr 01, 2026 · Last active Jul 02, 2026

Sentiment
32
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 65
Business
Junshi Biosciences licenses roconkibart to Fosun Wanbang
Impact: Fosun Pharmaceutical Group's subsidiary, Fosun International — Fosun Wanbang Pharma Group, entered into a strategic partnership with Shanghai Junshi Biosciences Co., Ltd, which is a vital step in continuously enriching its portfolio of high-value pipelines in the immunology and inflammation fields.
Jul 01, 2026 · 8 articles
2 0
Business
Ardelyx Appoints Rajani Dinavahi CMO
Impact: Fosun Pharmaceutical Group has an approved New Drug Application for tenapanor for hyperphosphatemia in China, a product related to Ardelyx's pipeline.
Apr 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Fosun Pharmaceutical Group live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.